Literature DB >> 22907331

Functions of scavenger receptor class B, type I in atherosclerosis.

Chieko Mineo1, Philip W Shaul.   

Abstract

PURPOSE OF REVIEW: This review highlights the diverse roles of the high-affinity HDL receptor scavenger receptor class B, type I (SR-BI) in the modulation of global cholesterol homeostasis and vascular cell function, and the potential implications of these processes in atherosclerosis. RECENT
FINDINGS: SR-BI in the liver plays a critical role in reverse cholesterol transport and it dramatically impacts the characteristics of the HDL particle, and through reverse cholesterol transport it promotes an antiatherogenic lipid environment in the vascular wall. SR-BI in macrophages may influence their inflammatory phenotype. In endothelial cells, SR-BI mediates HDL-induced endothelial nitric oxide synthase activation and proliferation and migration, and in platelets SR-BI may be prothrombotic in the setting of dyslipidemia. Several polymorphisms of SR-BI have been reported in humans that influence receptor expression or function.
SUMMARY: In addition to regulating global lipid metabolism, SR-BI influences the functions of a variety of vascular cells relevant to atherosclerosis. Studies of SR-BI genetics in humans partially support the conclusions drawn from experimental models. However, because of the multiple functions of SR-BI, the diversity of cell types in which it is expressed, and the influence of the receptor on the characteristics of its own ligand, our understanding of the biology of the receptor is just emerging.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22907331     DOI: 10.1097/MOL.0b013e328357ba61

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  32 in total

1.  Noncanonical role of the PDZ4 domain of the adaptor protein PDZK1 in the regulation of the hepatic high density lipoprotein receptor scavenger receptor class B, type I (SR-BI).

Authors:  Kosuke Tsukamoto; Thomas E Wales; Kathleen Daniels; Rinku Pal; Ren Sheng; Wonhwa Cho; Walter Stafford; John R Engen; Monty Krieger; Olivier Kocher
Journal:  J Biol Chem       Date:  2013-05-17       Impact factor: 5.157

Review 2.  Scavenger receptors in homeostasis and immunity.

Authors:  Johnathan Canton; Dante Neculai; Sergio Grinstein
Journal:  Nat Rev Immunol       Date:  2013-08-09       Impact factor: 53.106

Review 3.  Scavenger receptor class B type I (SR-BI): a versatile receptor with multiple functions and actions.

Authors:  Wen-Jun Shen; Jie Hu; Zhigang Hu; Fredric B Kraemer; Salman Azhar
Journal:  Metabolism       Date:  2014-03-21       Impact factor: 8.694

Review 4.  Novel concepts in HDL pharmacology.

Authors:  Alan T Remaley; Giuseppe D Norata; Alberico L Catapano
Journal:  Cardiovasc Res       Date:  2014-06-20       Impact factor: 10.787

5.  Disorders of cholesterol metabolism and their unanticipated convergent mechanisms of disease.

Authors:  Frances M Platt; Christopher Wassif; Alexandria Colaco; Andrea Dardis; Emyr Lloyd-Evans; Bruno Bembi; Forbes D Porter
Journal:  Annu Rev Genomics Hum Genet       Date:  2014       Impact factor: 8.929

6.  Scavenger receptor BI and high-density lipoprotein regulate thymocyte apoptosis in sepsis.

Authors:  Ling Guo; Zhong Zheng; Junting Ai; Deborah A Howatt; Paul R Mittelstadt; Seth Thacker; Alan Daugherty; Jonathan D Ashwell; Alan T Remaley; Xiang-An Li
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-03-06       Impact factor: 8.311

7.  Hepatic scavenger receptor BI protects against polymicrobial-induced sepsis through promoting LPS clearance in mice.

Authors:  Ling Guo; Zhong Zheng; Junting Ai; Bin Huang; Xiang-An Li
Journal:  J Biol Chem       Date:  2014-04-09       Impact factor: 5.157

8.  The atherogenic Scarb1 null mouse model shows a high bone mass phenotype.

Authors:  Corine Martineau; Louise Martin-Falstrault; Louise Brissette; Robert Moreau
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-11-19       Impact factor: 4.310

9.  15-lipoxygenase-mediated modification of HDL3 impairs eNOS activation in human endothelial cells.

Authors:  Lucia Cutuli; Angela Pirillo; Patrizia Uboldi; Hartmut Kuehn; Alberico L Catapano
Journal:  Lipids       Date:  2014-02-26       Impact factor: 1.880

Review 10.  Cholesterol Metabolism in CKD.

Authors:  Allison B Reiss; Iryna Voloshyna; Joshua De Leon; Nobuyuki Miyawaki; Joseph Mattana
Journal:  Am J Kidney Dis       Date:  2015-09-01       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.